Gert De Meerleer
Papers
7
Total Citations
86
H-Index
5
About
Gert De Meerleer is a leading radiation oncologist and professor at Ghent University Hospital whose research has fundamentally shaped the management of prostate cancer and oligometastatic disease. His work spans the full spectrum of prostate cancer care, from early-stage treatment decision-making to salvage therapies for recurrent disease. Notably, his 2019 study on the "Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification" (35 citations) demonstrated how advanced imaging refines risk stratification, directly influencing clinical guidelines. De Meerleer has been at the forefront of stereotactic body radiotherapy (SBRT), with his 2020 investigation into robotic SBRT for oligorecurrent pulmonary metastases (23 citations) establishing benchmarks for treating limited metastatic spread with minimal toxicity. He has also critically evaluated surgical salvage approaches, comparing robot-assisted versus open lymph node dissection in recurrent prostate cancer (13 citations), and developed standardized questionnaires to understand cognitive factors in treatment decision-making for localized disease. His contributions extend to high-intensity focused ultrasound versus radiation therapy debates and salvage vesiculectomy techniques, reflecting a career dedicated to optimizing outcomes through precision radiotherapy and evidence-based treatment algorithms.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7